Long-term outcome of sacral neuromodulation for chronic refractory constipation
Web of Science
AuthorMaeda, Y; Kamm, MA; Vaizey, CJ; Matzel, KE; Johansson, C; Rosen, H; Baeten, CG; Laurberg, S
Source TitleTechniques in Coloproctology
PublisherSPRINGER-VERLAG ITALIA SRL
University of Melbourne Author/sKamm, Michael
AffiliationMedicine and Radiology
Document TypeJournal Article
CitationsMaeda, Y., Kamm, M. A., Vaizey, C. J., Matzel, K. E., Johansson, C., Rosen, H., Baeten, C. G. & Laurberg, S. (2017). Long-term outcome of sacral neuromodulation for chronic refractory constipation. TECHNIQUES IN COLOPROCTOLOGY, 21 (4), pp.277-286. https://doi.org/10.1007/s10151-017-1613-0.
Access StatusOpen Access
PURPOSE: Sacral neuromodulation has been reported as a treatment for severe idiopathic constipation. This study aimed to evaluate the long-term effects of sacral neuromodulation by following patients who participated in a prospective, open-label, multicentre study up to 5 years. METHODS: Patients were followed up at 1, 3, 6, 12, 24, 36, 48 and 60 months. Symptoms and quality of life were assessed using bowel diary, the Cleveland Clinic constipation score and the Short Form-36 quality-of-life scale. RESULTS: Sixty-two patients (7 male, median age 40 years) underwent test stimulation, and 45 proceeded to permanent implantation. Twenty-seven patients exited the study (7 withdrawn consent, 7 loss of efficacy, 6 site-specific reasons, 4 withdrew other reasons, 2 lost to follow-up, 1 prior to follow-up). Eighteen patients (29%) attended 60-month follow-up. In 10 patients who submitted bowel diary, their improvement of symptoms was sustained: the number of defecations per week (4.1 ± 3.7 vs 8.1 ± 3.4, mean ± standard deviation, p < 0.001, baseline vs 60 months) and sensation of incomplete emptying (0.8 ± 0.3 vs 0.2 ± 0.1, p = 0.002). In 14 patients (23%) with Cleveland Clinic constipation score, improvement was sustained at 60 months [17.9 ± 4.4 (baseline) to 10.4 ± 4.1, p < 0.001]. Some 103 device-related adverse events were reported in 27 (61%). CONCLUSION: Benefit from sacral neuromodulation in the long-term was observed in a small minority of patients with intractable constipation. The results should be interpreted with caution given the high dropout and complication rate during the follow-up period.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References